Reproductive · Gynecology
The facts most likely to be tested
Premature ovarian insufficiency is defined as hypergonadotropic hypogonadism occurring before the age of 40 years.
The hallmark laboratory finding is an elevated serum FSH level on two occasions at least one month apart.
Patients typically present with secondary amenorrhea, vasomotor symptoms (hot flashes), and atrophic vaginitis due to estrogen deficiency.
Karyotype analysis is mandatory in all patients to rule out Turner syndrome (45,X) or FMR1 premutation associated with Fragile X-associated primary ovarian insufficiency.
The most common identifiable cause of premature ovarian insufficiency is autoimmune oophoritis, often associated with other conditions like Addison's disease or thyroiditis.
Hormone replacement therapy (HRT) is the standard of care to prevent osteoporosis and cardiovascular disease until the average age of natural menopause.
Patients with premature ovarian insufficiency have a 5-10% chance of spontaneous conception, making contraception necessary if pregnancy is not desired.
Vignette unlocked
A 32-year-old woman presents to the clinic complaining of 8 months of amenorrhea and frequent night sweats. She reports a history of regular menses until last year and denies any recent weight loss, excessive exercise, or medication use. Physical examination reveals atrophic vaginal mucosa and sparse pubic hair. Laboratory evaluation shows a markedly elevated serum FSH and a low serum estradiol level. A pregnancy test is negative.
What is the most appropriate next step in the management of this patient?
Karyotype analysis
The patient meets the criteria for premature ovarian insufficiency; karyotype analysis is required to rule out genetic causes such as Turner syndrome or FMR1 premutations.
Full handout
High yield triage
Etiology / Epidemiology
Defined as hypergonadotropic hypogonadism before age 40. Autoimmune conditions and Turner syndrome are primary drivers.
Clinical Manifestations
Presents as secondary amenorrhea with vasomotor symptoms (hot flashes, night sweats) and vaginal dryness.
Diagnosis
FSH levels >40 IU/L on two occasions at least one month apart confirm the diagnosis.
Treatment
Estrogen replacement therapy (with progestin if uterus present) is the standard to prevent bone loss.
Prognosis
High risk of osteoporosis and cardiovascular disease; requires long-term DEXA scan monitoring.
Full handout
Epidemiology & Etiology
Occurs in 1% of women under 40. Etiologies include autoimmune oophoritis, iatrogenic causes (chemotherapy/radiation), and genetic factors like Fragile X premutation. Always screen for Turner syndrome (45,X) in primary amenorrhea cases.
Pertinent Anatomy
The ovaries undergo premature follicular depletion or dysfunction. Loss of ovarian feedback leads to a compensatory rise in pituitary gonadotropins.
Pathophysiology
Follicular exhaustion or resistance to gonadotropins results in hypoestrogenism. The loss of negative feedback causes a massive rise in FSH and LH. This hormonal milieu mimics natural menopause but occurs prematurely.
Clinical Manifestations
Patients present with secondary amenorrhea, infertility, and symptoms of estrogen deficiency. Look for atrophic vaginitis and dyspareunia. Red flag: Always rule out pregnancy with a hCG test before diagnosing.
Diagnosis
The gold standard is elevated FSH >40 IU/L on two separate occasions. Perform a karyotype to rule out Y-chromosome material, which carries a high risk of gonadoblastoma.
Treatment
Hormone replacement therapy (HRT) is the first-line treatment to mitigate menopausal symptoms and bone loss. Contraindications include history of breast cancer, undiagnosed vaginal bleeding, or active thromboembolic disease. Progestin must be added if the patient has a uterus to prevent endometrial hyperplasia.
Prognosis
Patients face significant long-term risks of osteoporosis and early cardiovascular disease. Annual DEXA scans are recommended to monitor bone mineral density.
Differential Diagnosis
Pregnancy: ruled out by serum hCG
Hypothalamic amenorrhea: low/normal FSH and LH
Hyperprolactinemia: elevated prolactin levels
Thyroid disease: abnormal TSH/T4
PCOS: elevated androgens and normal/low FSH